Overall, positive expression of CK5/6, CK20, and GATA3 was identified in 47.4% (n = 54), 49.1% (n = 56), and 46.5% (n = 53) of UTUC cases, respectively (Figure 1). This evidence concerns the gene KRT5 and renal pelvis/ureter urothelial carcinoma.